A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors
Leap Therapeutics, Inc.
Leap Therapeutics, Inc.
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Northwestern University